NCT03666884View on ClinicalTrials.gov

The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 10, 2015

Primary Completion Date

March 15, 2016

Study Completion Date

October 25, 2016

Conditions
Dry Eye Syndrome
Interventions
DRUG

COE 2*1 (Restasis) + PFAT Refresh Single dose) 8*1

clinical improvement in oxford scale, ocular surface disease index, schirmers test, tear break up time, fluorescein staining of eye

BIOLOGICAL

AS 50% eye drops 8*1

clinical improvement in oxford scale, ocular surface disease index, schirmers test, tear break up time, fluorescein staining of eye

All Listed Sponsors
collaborator

Usak State Hospital

OTHER

lead

Seref istek

OTHER

NCT03666884 - The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome | Biotech Hunter | Biotech Hunter